Laminarin‑induced apoptosis in human colon cancer LoVo cells

Ji,Chen‑Feng; Ji,Yu‑Bin

doi:10.3892/ol.2014.1952

Laminarin‑induced apoptosis in human colon cancer LoVo cells

Authors:
- Chen‑Feng Ji
- Yu‑Bin Ji
View Affiliations

Affiliations: Engineering Research Center of Natural Anticancer Drugs, Ministry of Education, Harbin, Heilongjiang 150076, P.R. China, Engineering Research Center of Natural Anticancer Drugs, Ministry of Education, Harbin, Heilongjiang 150076, P.R. China
Published online on: March 7, 2014 https://doi.org/10.3892/ol.2014.1952
Pages: 1728-1732

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A number of scientific studies have revealed that laminarin has antitumor effects. Therefore, the aim of the present study was to investigate the apoptosis of LoVo cells and the underlying mechanisms induced by laminarin. LoVo cells were treated with various concentrations of laminarin and fluorescence‑inverted microscopy was used to observe the morphology of LoVo cells treated with laminarin. In addition, western blotting was performed to analyze the expression levels of death receptor (DR)4, DR5, TNF‑related apoptosis‑inducing ligand (TRAIL), Fas‑associated protein with death domain (FADD), caspase‑8, caspase‑3, Bid and tBid. Flow cytometry was conducted to analyze the expressions of Bcl‑2 and Bax, and spectrophotometry was performed to quantify the activity of caspases‑8, ‑3, ‑6 and ‑7. Following the treatment of LoVo cells with laminarin for 24 h, the expression levels of DR4, DR5, TRAIL, FADD, Bid, tBid and Bax were observed to be upregulated, whereas the expression levels of pro‑caspase‑8, pro‑caspase‑3 and Bcl‑2 were downregulated. In addition, the activities of casapse‑8, ‑3, ‑6 and ‑7 were observed to increase, which was a significant difference when compared with those of the control group. Therefore, laminarin is considered to induce the apoptosis of LoVo cells, which may occur via a DR pathway, suggesting that laminarin may be a potent agent for cancer treatment.

View Figures

View References

1	Yuan XL, Lv JZ, Xiao J and Ma Q: Research progress of Laminarin. An Hui Nang Ye Ke Xue Bian Ji Bu. 27:15447–15448. 154522010.(In Chinese).
2	Ji CF, JI YB and Meng DY: Sulfated modification and anti-tumor activity of laminarin. Exp Ther Med. 6:1259–1264. 2013.PubMed/NCBI
3	Fuentes AL, Millis L and Sigola LB: Laminarin, a soluble beta-glucan, inhibits macrophage phagocytosis of zymosan but has no effect on lipopolysaccharide mediated augmentation of phagocytosis. Int Immunopharmacol. 11:1939–1945. 2011. View Article : Google Scholar
4	Lee JY, Kim YJ, Kim HJ, et al: Immunostimulatory effect of laminarin on RAW 264.7 mouse macrophages. Molecules. 17:5404–5411. 2012. View Article : Google Scholar : PubMed/NCBI
5	Kim EJ, Lee YJ, Shin HK and Yoon JH: A study on the mechanism by which the aqueous extract of Inonotus obliquus induces apoptosis and inhibits proliferation in HT-29 human colon cancer cells. J Korean Soc Food Sci Nutr. 35:516–523. 2006.
6	Park HK, Kim IH, Kim J and Nam JJ: Induction of apoptosis by laminarin, regulating the insulin-like growth factor-IR signaling pathways in HT-29 human colon cells. Int J Mol Med. 30:734–738. 2012.PubMed/NCBI
7	Ji YB, Ji CF and Zhang H: Laminarin induces apoptosis of human colon cancer LOVO cells through a mitochondrial pathway. Molecules. 17:9947–9960. 2012. View Article : Google Scholar : PubMed/NCBI
8	Brenner D and Mak TW: Mitochondrial cell death effectors. Curr Opin Cell Biol. 21:871–877. 2009. View Article : Google Scholar
9	Jeong SY and Seol DW: The role of mitochondria in apoptosis. BMB Rep. 41:11–22. 2008. View Article : Google Scholar
10	Mellier G, Huang S, Shenoy K and Perraiz S: TRAILing death in cancer. Mol Aspects Med. 31:93–112. 2010. View Article : Google Scholar
11	Krysko DV, Vanden Berghe T, D’Herde K and Vandenabeele P: Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods. 44:205–221. 2008. View Article : Google Scholar
12	Kleinberg L and Davidson B: Cell survival and apoptosis-related molecules in cancer cells in effusions: a comprehensive review. Diagn Cytopathol. 37:613–624. 2009. View Article : Google Scholar : PubMed/NCBI
13	Hori T, Kondo T, Kanamori M, et al: Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells. J Orthop Res. 28:739–745. 2010.
14	Szliszka E, Mazur B, Zydowicz G, et al: TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells. Folia Histochem Cytobiol. 47:579–585. 2009.PubMed/NCBI
15	Pennarun B, Meijer A, de Vries EG, et al: Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer. Biochim Biophys Acta. 1805:123–140. 2010.PubMed/NCBI
16	Mazurek N, Byrd JC, Sun YJ and Bresalier R: W1930 nuclear galectin-3 confers tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) resistance to colon cancer cells by inhibiting Caspase-8 activation. Gastroenterology. 136:A-7562009. View Article : Google Scholar
17	Naumann I, Kappler R, von Schweinitz D, et al: Bortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathway. Clin Cancer Res. 17:3204–3218. 2011. View Article : Google Scholar
18	Kantari C and Walczak H: Caspase-8 and bid: caught in the act between death receptors and mitochondria. Biochim Biophys Acta. 1813:558–563. 2011. View Article : Google Scholar : PubMed/NCBI
19	Fei BJ, Chi AL and Weng Y: Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression. World J Surg Oncol. 11:120–128. 2013. View Article : Google Scholar : PubMed/NCBI
20	Ghiotto F, Fais F and Bruno S: BH3-only proteins: the death-puppeteer’s wires. Cytometry A. 77:11–21. 2010.PubMed/NCBI
21	Repnik U and Turk B: Lysosomal-mitochondrial cross-talk during cell death. Mitochondrion. 10:662–669. 2010. View Article : Google Scholar : PubMed/NCBI
22	Song G, Chen GG, Hu T and Lai PB: Bid stands at the crossroad of stress-response pathways. Curr Cancer Drug Targets. 10:584–592. 2010. View Article : Google Scholar : PubMed/NCBI
23	Golbano JM, Lóppez-Aparicio P, Recio MN and Pérez-Albarsanz MA: Finasteride induces apoptosis via Bcl-2, Bcl-xL, Bax and caspase-3 proteins in LNCaP human prostate cancer cell line. Int J Oncol. 32:919–924. 2008.PubMed/NCBI
24	Shore GC and Nguyen M: Bcl-2 proteins and apoptosis: choose your partner. Cell. 135:1004–1006. 2008. View Article : Google Scholar : PubMed/NCBI
25	Zhang ZF, Guo Y, Zhang JB and Wei XH: Induction of apoptosis by chelerythrine chloride through mitochondrial pathway and Bcl-2 family proteins in human hepatoma SMMC-7721 cell. Arch Pharm Res. 34:791–800. 2011. View Article : Google Scholar : PubMed/NCBI